LATEST RESEARCH

Research

Independent analysis of SEC filings, private funds, RIAs, websites and regulatory records.

Public Pension Capital SEC Review 2026: $2.17B Form D, PPC Enterprises and Investment Risks
INDEPENDENT RESEARCH

Public Pension Capital SEC Review 2026: $2.17B Form D, PPC Enterprises and Investment Risks

Public Pension Capital, LLC is a Delaware private equity investment entity associated with PPC Enterprises, an established New York investment management platform specializing in middle-market businesses. Its September 24, 2026 Form D amendment reports approximately $2.17 billion in cumulative securities sales, representing an increase of $245 million from the previous year's filing. Unlike newly organized private funds with limited operating histories, Public Pension Capital has maintained a regulatory filing record since 2014 and operates within a management platform with identifiable leadership, institutional investors and a documented portfolio of operating businesses. PPC focuses on industrial services, business and financial services, and healthcare services, using a long-term ownership strategy intended to support operational development and enterprise value creation. Nevertheless, the substantial cumulative fundraising figure should not be confused with current net asset value, realized investment profits or capital immediately available for distribution. The fund's long operating history also introduces questions concerning historical investment valuations, capital recycling, portfolio concentration and the treatment of older investments. Investors should distinguish the manager's institutional background from the actual economic rights and financial performance attributable to Public Pension Capital itself.

Public Pension Capital, LLC · CIK 0001609477Read article →
Tru Arrow Technology Partners II SEC Review: $110.7M Raise, Fees and Offshore Fund Risks
INDEPENDENT RESEARCH

Tru Arrow Technology Partners II SEC Review: $110.7M Raise, Fees and Offshore Fund Risks

Tru Arrow Technology Partners II, LP is a Delaware venture capital investment vehicle associated with Tru Arrow Management and investor Glenn Fuhrman. Its September 23, 2026 amended Form D reports $110.67 million in cumulative securities sold to 62 investors, compared with $74.27 million and 47 investors in its original September 2025 filing. The increase establishes a documented expansion in reported fundraising, but it does not establish current net asset value, realized profits or the amount of capital already deployed into technology companies. The fund's structure deserves particular attention because a separately registered Cayman Islands vehicle, Tru Arrow Technology Partners Offshore II, operates alongside the US partnership and identifies the same investment manager and general partner. The available records do not establish whether their assets are completely overlapping, independently allocated or held through a common investment structure. A further financial concern appears in the fund's own regulatory disclosures: although related-person payments and sales commissions are reported as zero, the investment manager expressly receives customary management fees. The principal due-diligence issues therefore concern fund-level performance, domestic and offshore vehicle relationships, investment allocation, fee transparency and the valuation of potentially illiquid technology investments. These documented questions do not establish fraud or regulatory misconduct, but they require more detailed contractual and financial evidence than Form D provides.

Tru Arrow Technology Partners II, LP · CIK 0002086380Read article →
Aromha SEC Review 2026: Brain Health Test, FDA Status and Funding Risks
INDEPENDENT RESEARCH

Aromha SEC Review 2026: Brain Health Test, FDA Status and Funding Risks

Aromha, Inc. is a Delaware healthcare technology company developing an at-home olfactory screening platform intended to identify changes in smell function that may be associated with cognitive impairment and neurodegenerative disease. Its corporate identity is supported by SEC filings under CIK 0002047430, while its scientific foundation includes a peer-reviewed 2025 study involving researchers from Massachusetts General Hospital and Harvard Medical School. These records distinguish Aromha from a business relying entirely on unsupported medical marketing claims. Nevertheless, its September 2026 financing and clinical positioning reveal several material issues requiring closer examination. The latest Form D reports only $75,000 sold to one investor, while earlier filings identify separate financing activity, including a $3 million offering that had recorded just $250,000 in sales at its October 2025 filing date. The company also declined to disclose its revenue range, limiting public assessment of commercial adoption and financial sustainability. More importantly, the Aromha Brain Health Test is presented as an FDA-registered, 510(k)-exempt medical device for screening olfactory loss, not an FDA-approved diagnostic test for Alzheimer's disease. Its published research supports investigation of olfactory biomarkers but does not establish reliable prediction of future dementia across the general population. Investors should distinguish genuine research activity, medical-device registration and historical research grants from independently demonstrated clinical utility, recurring commercial revenue and sustainable investment value.

Aromha · CIK 0002047430Read article →
EDL Global Opportunities Fund SEC Review: $54.5M Offering, Macro Losses and Investor Risks
INDEPENDENT RESEARCH

EDL Global Opportunities Fund SEC Review: $54.5M Offering, Macro Losses and Investor Risks

EDL Global Opportunities Fund Ltd is an established Cayman Islands hedge fund associated with EDL Capital and global macro investor Edouard de Langlade. Its September 23, 2026 SEC Form D/A reports $54.47 million in cumulative securities sold to four investors, with an indefinite offering amount and a $100,000 minimum investment. The fund has operated for several years and should not be presented as a newly launched 2026 investment vehicle. The most consequential investor concern is the contrast between the manager's publicly reported periods of substantial profitability and its exposure to significant macro trading losses. Bloomberg reported that EDL Global Opportunities Master Fund declined approximately 11% in March 2026, demonstrating that even an established macro strategy can experience material losses when market conditions change abruptly. This reported Master Fund result should not automatically be treated as the exact net return of the Cayman Ltd issuer or its individual share classes. A further issue concerns the existence of a separately registered Cayman limited partnership with a substantially different fundraising record. Investors must distinguish the legal entities, their contractual rights and their respective financial disclosures before interpreting the sponsor's aggregate investment history. The available evidence supports meaningful concerns involving performance volatility, derivatives exposure, management fees, cross-border structures and investor liquidity, but does not establish fraud or regulatory misconduct.

EDL Global Opportunities Fund Ltd · CIK 0001653166Read article →
SEC VERIFYINDEPENDENT
RESEARCH
SEC Filings · Verification · Analysis
INDEPENDENT RESEARCH

Independent Access Partners UForce SPV SEC Review: Defense Tech Investment and Risks

Independent Access Partners UForce SPV SEC Review: Defense Technology, Fund Structure and Investment Risks

Independent Access Partners UForce SPV, LLCRead article →
Honduras Prospera SEC Review 2026: $45M Offering, ZEDE Dispute and Arbitration Risks
INDEPENDENT RESEARCH

Honduras Prospera SEC Review 2026: $45M Offering, ZEDE Dispute and Arbitration Risks

Honduras Prospera Inc. is a Delaware corporation associated with Próspera ZEDE, a special economic development project on the Honduran island of Roatán. Its SEC filing history, identifiable management, operating development activities and participation in international investment arbitration establish a documented corporate identity. However, the company's investment proposition faces unusually consequential legal and political uncertainty that extends well beyond conventional real estate development risk. Its January 2025 Form D reported $10 million sold against a $45 million equity offering, while a subsequent amendment was submitted in May 2026. More importantly, the Honduran government's repeal measures concerning the ZEDE framework and a 2024 Supreme Court ruling have created significant disagreement over the legal arrangements supporting the project. Honduras Prospera and related entities are pursuing international arbitration against the Republic of Honduras, but the existence of a claim does not establish entitlement to compensation or guarantee an enforceable recovery. The project's own legal stability disclosure acknowledges risks affecting property ownership, contracts, business operations, taxation and regulatory authority. Investors should distinguish the existence of a legitimate U.S. securities issuer from the legal status of its underlying Honduran development and the enforceability of rights associated with the special economic zone.

Honduras Prospera · CIK 0001881173Read article →
Prusik Asian Equity Income Fund SEC Review: $1B Fund, Fees and Performance Risks
INDEPENDENT RESEARCH

Prusik Asian Equity Income Fund SEC Review: $1B Fund, Fees and Performance Risks

Prusik Asian Equity Income Fund is an established Irish investment fund managed by Prusik Investment Management LLP, an independent investment specialist focused on Asian equities. Its investment history dates to December 2010, while its SEC Form D record identifies August 26, 2011 as the first sale date. The September 23, 2026 Form D/A reports zero securities sold and zero investors under the US exempt offering, yet the manager's September 2026 fund data identifies approximately $1.057 billion in total fund assets. These figures are not inherently contradictory because a US private offering notice does not represent the complete financial position of an internationally distributed Irish investment fund. The more significant investor concerns arise from documented management and performance fees, varying share-class economics and periods of substantial benchmark underperformance. Morningstar data for the Class X USD distributing shares shows a one-year return of 15.48% through August 28, 2026, compared with 34.79% for its displayed benchmark. The fund's income-oriented investment strategy also exposes investors to Asian equity volatility, foreign exchange movements and changes in corporate dividend policy. Its established operating history provides meaningful financial information, but neither the SEC filing nor the reported billion-dollar scale guarantees investment performance or capital preservation.

Prusik Asian Equity Income Fund · CIK 0001530611Read article →
SEC VERIFYINDEPENDENT
RESEARCH
SEC Filings · Verification · Analysis
INDEPENDENT RESEARCH

ASVFI LP SEC Review 2026: New Form D, Fund Transparency and Investment Risks

ASVFI, LP is a private pooled investment vehicle associated with Wheat Ridge, Colorado, whose September 24, 2026 Form D represents a newly reported exempt securities offering. Public filing databases identify the issuer within the pooled investment fund category and report no incremental securities sales at the initial filing date. Unlike investment vehicles associated with widely documented institutional sponsors, ASVFI currently has a limited independently accessible public profile, making the identification of its controlling entities, investment strategy and underlying assets particularly important. The available information does not establish a completed fundraising program, audited fund-level financial statements or a verifiable investment performance history. Its abbreviated legal name also provides insufficient evidence to attribute the issuer to another investment manager or operating company. The central due diligence issue is therefore the gap between a documented regulatory filing and the information necessary to assess the actual economic exposure represented by the securities. Investors should distinguish the existence of a private placement notice from proof of completed capital deployment, independently verified asset values or regulatory approval of the proposed investment.

ASVFI, LPRead article →
SEC VERIFYINDEPENDENT
RESEARCH
SEC Filings · Verification · Analysis
INDEPENDENT RESEARCH

OZE JM Fund I SEC Review: $6.92M Form D, Fund Structure and Investment Risks

OZE JM Fund I LLC is a private investment issuer whose September 24, 2026 Form D filing reports approximately $6.92 million in securities sales. The filing establishes a newly reported private capital transaction, but the available public information does not independently identify the fund's complete ownership structure, investment manager or underlying portfolio. Unlike a publicly registered investment company with extensive financial reporting obligations, this issuer provides limited publicly accessible information about its financial position and investment economics. The distinction is important because reported fundraising does not establish the value of assets acquired, the amount of capital remaining available for investment or the financial return attributable to investors. The fund's name also does not establish a specific investment strategy or a verified relationship with another financial institution. Investors should therefore assess OZE JM Fund I as an independent legal issuer rather than relying on assumptions about the OZE or JM designations. The principal concern is the limited transparency surrounding the deployment of the reported capital, the financial condition of the underlying investments and the contractual rights available to investors.

OZE JM Fund I LLCRead article →
LibreMax Inter CAVU Partners SEC Review: $10.85M Fund, Fees and Credit Risks
INDEPENDENT RESEARCH

LibreMax Inter CAVU Partners SEC Review: $10.85M Fund, Fees and Credit Risks

LibreMax Inter CAVU Partners, LP is a Delaware hedge fund associated with LibreMax Capital, an established alternative credit investment manager led by Greg Lippmann. Its September 2026 amended Form D reports $10.85 million in cumulative securities sold to 22 investors, unchanged from the original offering disclosure. The fund therefore has a documented fundraising history, but its public regulatory record does not establish current audited net asset value, realized investment performance or the complete composition of its portfolio. One particularly important finding concerns compensation: although the issuer reports zero sales commissions and zero related-person payments in the relevant numerical fields, it expressly states that the fund charges a management fee described in its offering documents. A separate concern arises from LibreMax's extensive network of structured credit vehicles and its 2026 application concerning affiliated co-investment transactions. These arrangements raise questions about opportunity allocation, related-party transactions and the treatment of investments held across different vehicles. The available evidence establishes an identifiable investment manager and legitimate subjects for due diligence, but does not prove misconduct by Inter CAVU. Its investment economics, liquidity and underlying credit exposures require vehicle-specific verification.

LibreMax Inter CAVU Partners, LP · CIK 0002086741Read article →
Eclipse Bancorp SEC Review 2026: $13M Debt Offering, Bank Financials and Investor Risks
INDEPENDENT RESEARCH

Eclipse Bancorp SEC Review 2026: $13M Debt Offering, Bank Financials and Investor Risks

Eclipse Bancorp, Inc. is an established Kentucky bank holding company with an identifiable SEC filing history, a regulated banking subsidiary and publicly available financial information. Its September 23, 2026 Form D reports a completed $13 million debt securities offering involving 11 investors, marking another significant capital transaction following its approximately $15 million equity offering in 2022. Unlike a private financial issuer supported only by promotional materials, Eclipse has an operating banking business, identifiable management, FDIC-regulated subsidiary operations and historical financial statements. However, its latest fundraising should not be interpreted as evidence that the company has eliminated credit, liquidity or capital-structure risks. The securities offered are debt rather than ordinary bank deposits, and the Form D identifies a $325,000 sales commission associated with the transaction. Eclipse Bank's June 2026 regulatory figures also show substantial exposure to real estate-secured lending, while earlier shareholder information indicates deterioration in the reported non-performing loan ratio during the first quarter of 2026. The bank remains profitable on the available mid-year figures, but profitability does not eliminate the possibility of future credit losses, interest-rate pressure or increased funding costs. Investors should distinguish the regulated operating bank from its holding company, establish the precise ranking and repayment terms of the new debt, and avoid confusing FDIC-insured customer deposits with uninsured investment securities issued by the parent.

Eclipse Bancorp · CIK 0001946412Read article →
SEC VERIFYINDEPENDENT
RESEARCH
SEC Filings · Verification · Analysis
INDEPENDENT RESEARCH

Carlton at Greenbrier DST SEC Review: 176-Unit Property, 1031 Exchange and Investment Risks

Carlton at Greenbrier DST is a newly reported private real estate investment issuer whose September 24, 2026 Form D introduces an investment structure associated by name with The Carlton at Greenbrier, a multifamily apartment property in Chesapeake, Virginia. The underlying property is identifiable in Bonaventure's published portfolio, which describes a 176-unit residential community built in 2012. Unlike a private investment vehicle whose commercial purpose cannot be traced beyond its legal name, this offering has a potentially identifiable physical asset and an established regional real estate context. Nevertheless, the public information reviewed does not independently establish the precise ownership relationship between the DST issuer and the property, the acquisition valuation, outstanding mortgage obligations or actual investor-level distribution terms. Third-party filing data reports no incremental securities sales at the initial filing date, making it particularly important to distinguish the establishment of a securities offering from completed fundraising. The principal investment concern is whether the property's operating income and financing arrangements can support distributions while preserving sufficient capital for maintenance, debt service and eventual disposition. Investors should not treat an identifiable apartment building, a sponsor's broader operating history or the existence of an SEC filing as evidence of guaranteed returns or independently verified investment value.

Carlton at Greenbrier DSTRead article →